This evidence together with the proven, although limited, clinical effect of cholinesterase inhibitors in the treatment of cognitive impairment in AD (Anand & Singh, 2013) strongly support the involvement of mAChRs in tau pathology. Here, MAPT is linked to Alzheimer disease.